His lab focuses on the biology and genetics of CRISPR/Cas immune systems in bacteria. He also serves as the Chairman of the Board of Directors of Caribou Biosciences. Rodolphe was previously a Director of Research and Development at DuPont and Danisco. While with Dansico, he was part of the team that initially established the adaptive immune function of CRISPR systems. Dr. Barrangou hold 9 patents related to CRISPR/Cas9 and has published more than 100 papers and 7 book chapters in the field. For his work as a pioneer in CRISPR/Cas9, he has been awarded the distinguished Gairdner International Award and the Warren Alpert Foundation Prize.